Investors in Healthtec

Praetura are a venture capital firm in the North West, who invest in early-stage businesses and provide 'more than money' support. We have developed a reputation for being a supportive and proactive investor who injects more than just capital. We can evidence the value from our differentiated approach from both investment returns and testament from our portfolio companies. Our partnered entrepreneurs embrace the shoulder to shoulder Praetura approach and utilise our experience and resource to maximise their businesses’ potential.

blisce/ is an investment firm co-headquartered in New York and Paris that is committed to investing differently. Pragmatically optimistic that entrepreneurship, innovation, and purposeful capital can improve our world, we empower people to take real action. We work to be genuinely aligned with all our stakeholders because we believe there is no acceptable financial performance without responsibility. Since 2014, blisce/ has invested in leading U.S. and European companies – including Spotify, Pinterest, Headspace, & Too Good To Go – with 8 exits. blisce/ was the first transatlantic fund to be certified as a B Corp.

83North is a global venture capital firm with more than $2B under management that invests in European and Israeli entrepreneurs creating global businesses. In their 18 years of operation they’ve invested in 89 companies, exited 32 of them and have been fortunate to be involved with 14 unicorns.

Cogito Capital Partners is a venture capital firm based in Warsaw, Poland and New York, USA. We partner with ambitious entrepreneurs and support growth of later-stage B2B tech companies with CEE footprint and products & services that have potential to scale globally and transform the key 3 sectors: Enterprise software, Fintech and Healthtech.

Headline is a Venture Capital firm actively on the ground in 7 cities around the world. We invest across geographies, leading rounds at every stage. Once we commit to a team, we go to the ends of the earth to make their success global. Our Early Stage Funds are based in the US, Europe, Asia, and Brazil, and invest locally. Our San Francisco-based Growth Fund invests globally from Series B and beyond, working in collaboration with our Early Stage Teams. The sizes and locations of these funds make it possible for us to see local trends up close, identify winning founders, and lead rounds at every stage. Sonos, The RealReal, Creditas, Sorare, Pismo, AppFolio, goPuff, Acorns, Farfetch, Segment, Bumble and Yeahka are among the stars in Headline’s world.

Lightrock is a global investment platform dedicated to building a sustainable future. Headquartered in London, Lightrock manages capital across both public and private markets, a significant portion of which is dedicated to climate innovation.

InHealth Ventures (IHV) is a London-based early stage venture capital fund investing in tech-enabled healthcare and life sciences. We back founders working to reengineer healthcare, and use our deep experience, strategic insights and global network to accelerate their journey from Seed to Series A and beyond. IHV’s mission is to contribute to bending the healthcare cost curve, improving patient access and outcomes while enhancing the working lives of clinical and non-clinical staff.

Qbic is a seed and early-stage venture capital fund supporting spin-offs and start-ups that valorize research from Qbic's knowledge partners. Qbic is one of the largest spin-off funds in Europe managing €190 million in resources over the different funds. Qbic I launched in 2012 and has finalized its portfolio of 18 ventures; Qbic II launched in 2017 and has a portfolio of 19 ventures, and Qbic III launched in 2022 and is currently building its portfolio.

At PUSH, we are committed to combat climate change and transform healthcare. Our initial investments are typically at pre-seed or seed stage with the potential to follow-on. Focus areas are health and future of the planet in Europe, especially Austria and Germany.

J&T Ventures is an early-stage Prague based Venture Capital fund, which invests into promising startups from the CEE and SEE region. Our strategy is industry agnostic, but we primarily focus on companies in seed stage with proven product market fit. Our average ticket size is between 0.5m EUR - 3m EUR.

Empowering founders through funding and support. From the start of your journey to late growth, we have you covered, We invest and provide support to founders from the universities of Delft & Rotterdam. We help you accelerate through our early stage fund of €58M and our unique and expansive network.